Cherkaoui Malki M, Bardot O, Lhuguenot J C, Latruffe N
Laboratoire de Biochimie et Biologie Moléculaire (URA CNRS 531) Université de Franche-Comté, Besançon.
Biol Cell. 1990;69(2):83-92. doi: 10.1111/j.1768-322x.1990.tb00002.x.
Peroxisome proliferation induced by 2 hypolipidemic agents (clofibrate and ciprofibrate) was studied in rats by complementary approaches, ie cell fractionation, electron microscopy, marker enzyme activities, immunoblotting and nucleic acid hybridization techniques. Administration of clofibrates for 2 and 52 weeks in doses of 500 ppm and 50 ppm respectively, or ciprofibrate for 2,28 and 52 weeks in doses of 250, 25 and 25 ppm respectively, did not alter the behavior of the peroxisomes after induction as shown by ultracentrifugation profiles. The peroxisome mass was increased as shown by the purification procedure. Specific enzymes (catalase and mostly cyanide insensitive palmitoyl CoA oxidase) were induced. A mechanism of peroxisome biogenesis might have been initiated ie cytosolic factor, ligand-receptor interaction and/or post-translational modification of the import. Increase in marker enzyme activities showed that the peroxisomes are the most responsive organelles in comparison to lysosomes, mitochondria and smooth endoplasmic reticulum (except for cytochrome P-450 LA omega-hydroxylase). Peroxisomal integral membrane proteins appeared to be differently induced: some of them were virtually absent in untreated rat liver but were strongly expressed in treated liver. Induction was sustained for 52 weeks, indicating that there was no compensatory mechanism.
采用细胞分级分离、电子显微镜、标记酶活性、免疫印迹和核酸杂交技术等互补方法,研究了两种降血脂药物(氯贝丁酯和环丙贝特)在大鼠体内诱导的过氧化物酶体增殖情况。分别以500 ppm和50 ppm的剂量给予氯贝丁酯2周和52周,或以250 ppm、25 ppm和25 ppm的剂量给予环丙贝特2周、28周和52周,超速离心分析结果显示,诱导后过氧化物酶体的行为未发生改变。纯化过程表明过氧化物酶体质量增加。诱导了特异性酶(过氧化氢酶以及大部分对氰化物不敏感的棕榈酰辅酶A氧化酶)。可能启动了过氧化物酶体生物发生机制,即胞质因子、配体 - 受体相互作用和/或输入的翻译后修饰。标记酶活性的增加表明,与溶酶体、线粒体和平滑内质网(细胞色素P - 450 LA ω - 羟化酶除外)相比,过氧化物酶体是最敏感的细胞器。过氧化物酶体整合膜蛋白的诱导情况似乎有所不同:其中一些在未处理的大鼠肝脏中几乎不存在,但在处理过的肝脏中强烈表达。诱导持续了52周,表明不存在补偿机制。